136 related articles for article (PubMed ID: 36126701)
21. Labial pyogenic granuloma successfully treated with topical timolol in an adult.
Filippi F; Patrizi A; Veneziano L
Dermatol Ther; 2022 Apr; 35(4):e15307. PubMed ID: 34997801
[No Abstract] [Full Text] [Related]
22. Rapid Involution of Presumed Pyogenic Granuloma with Topical Timolol.
Priluck A; Bacorn C; Rajaii F
Ophthalmology; 2023 Jan; 130(1):27. PubMed ID: 35777985
[No Abstract] [Full Text] [Related]
23. Topical timolol for small infantile hemangioma: a new therapy option.
Weissenstein A; Straeter A; Villalon G; Bittmann S
Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
[TBL] [Abstract][Full Text] [Related]
24. Topical β-blockers for pyogenic granulomas: A promising option for younger patients.
El-Taweel AEI; Al-Refaie AAA; Salem KHA; Salem RM
J Cosmet Dermatol; 2021 Jun; 20(6):1801-1806. PubMed ID: 33128492
[TBL] [Abstract][Full Text] [Related]
25. Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials.
Dany M
J Drugs Dermatol; 2019 Oct; 18(10):1006-1010. PubMed ID: 31584779
[TBL] [Abstract][Full Text] [Related]
26. Combination of ligation and timolol before surgical excision of pyogenic granuloma.
Baek YS; Kwon SH; Jeon J
J Am Acad Dermatol; 2018 Jun; 78(6):e141-e142. PubMed ID: 29307642
[No Abstract] [Full Text] [Related]
27. Comment on "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas".
M Hill I; Stefanko N; Drolet BA
Pediatr Dermatol; 2018 Sep; 35(5):698-699. PubMed ID: 30211468
[No Abstract] [Full Text] [Related]
28. Response to "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas".
Rork JF; Prindaville B; Costa RD; Wiss K
Pediatr Dermatol; 2018 Sep; 35(5):700. PubMed ID: 30211462
[No Abstract] [Full Text] [Related]
29. Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.
Sibaud V; Casassa E; D'Andrea M
Support Care Cancer; 2019 Jul; 27(7):2341-2343. PubMed ID: 30847700
[TBL] [Abstract][Full Text] [Related]
30. Patient Perspectives: What is a pyogenic granuloma?
Pediatr Dermatol; 2018 Mar; 35(2):237-238. PubMed ID: 29575073
[No Abstract] [Full Text] [Related]
31. Topical timolol treatment for periocular infantile haemangioma in the developing world.
Jefferson RJ; Hildebrand GD
Trop Doct; 2019 Jul; 49(3):246-248. PubMed ID: 31014195
[TBL] [Abstract][Full Text] [Related]
32. A pyogenic granuloma treated with topical timolol.
Malik M; Murphy R
Br J Dermatol; 2014 Dec; 171(6):1537-8. PubMed ID: 24836966
[TBL] [Abstract][Full Text] [Related]
33. Topical beta-blockers in dermatologic therapy.
Filoni A; Ambrogio F; De Marco A; Pacifico A; Bonamonte D
Dermatol Ther; 2021 Jul; 34(4):e15016. PubMed ID: 34075667
[TBL] [Abstract][Full Text] [Related]
34. [Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas].
Zheng JW; Wang XK; Jiang CH; Qin ZP; Fan XD; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK; Lei SR
Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):744-747. PubMed ID: 28275803
[TBL] [Abstract][Full Text] [Related]
35. Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single-arm study.
Jaiswal H; Patidar N; Shah C; Singh R; Jain E; Piyush P
Indian J Ophthalmol; 2021 May; 69(5):1155-1160. PubMed ID: 33913850
[TBL] [Abstract][Full Text] [Related]
36. Ophthalmic Pyogenic Granulomas Treated With Topical Timolol-Clinical Features of 17 Cases.
DeMaria LN; Silverman NK; Shinder R
Ophthalmic Plast Reconstr Surg; 2018; 34(6):579-582. PubMed ID: 29634609
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomized, double-blind and placebo-controlled study.
Patra AC; Sil A; Ahmed SS; Rahaman S; Mondal N; Roy S; Datta A; Kaliyadan F; Panda S; Setia MS; Dogra S; Khandpur S; Hazra A; Das NK
Indian J Dermatol Venereol Leprol; 2022; 88(4):500-508. PubMed ID: 34672473
[TBL] [Abstract][Full Text] [Related]
38. Allergic contact dermatitis caused by timolol eyedrop application for infantile haemangioma.
Sacchelli L; Vincenzi C; La Placa M; Piraccini BM; Neri I
Contact Dermatitis; 2019 Apr; 80(4):255-256. PubMed ID: 30485454
[No Abstract] [Full Text] [Related]
39. Topical timolol maleate 0.5% for infantile capillary haemangioma of the eyelid.
Xue K; Hildebrand GD
Br J Ophthalmol; 2012 Dec; 96(12):1536-7. PubMed ID: 23014679
[No Abstract] [Full Text] [Related]
40. Topical timolol for periocular hemangioma: report of further study.
Ni N; Langer P; Wagner R; Guo S
Arch Ophthalmol; 2011 Mar; 129(3):377-9. PubMed ID: 21403002
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
